The peculiarity of community-acquired pneumonia (CAP) express-diagnostic by means of bacterioscopy

K. E. Bogatska, Y. V. Popovich (Dniepropetrovsk, Ukraine)

Source: Annual Congress 2004 - Community acquired and nosocomial pneumonia
Session: Community acquired and nosocomial pneumonia
Session type: Thematic Poster Session
Number: 2550
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. E. Bogatska, Y. V. Popovich (Dniepropetrovsk, Ukraine). The peculiarity of community-acquired pneumonia (CAP) express-diagnostic by means of bacterioscopy. Eur Respir J 2004; 24: Suppl. 48, 2550

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Atypical agents of community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Epidemiology of community-acquired pneumonia (CAP)
Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults
Year: 2015



Role of virus in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Community-acquired pneumonia
Source: Respipedia Article
Year: 2017

Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012

The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Antibiotic usage analysis for community-acquired pneumonia (CAP) treatment
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



One year analysis of hospital-treated, community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009


Community-acquired pneumonia (CAP) and pregnancy
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Clostridium difficile infection following community-acquired pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006